Reimagine Care – a leading provider of virtual-first cancer care – recently announced an investment from Oncology Ventures, a cancer-focused venture capital fund. This funding round marks a significant milestone in the combined pursuit of innovative and patient-centric approaches to cancer care delivery.
Oncology Ventures, which is renowned for its commitment to advancing oncology care and patient outcomes, recognized the transformative potential of Reimagine Care. The funding will facilitate the development and expansion of Reimagine Care’s product development and commercial acceleration.
Reimagine Care is at the forefront of utilizing technology and data-driven insights to create highly efficient and personalized healthcare solutions. By combining Oncology Venture’s commitment to the advancement of healthcare through innovative technologies with Reimagine Care’s visionary approach to cancer care delivery, this partnership aims to drive meaningful change in the industry.
KEY QUOTES:
“We are excited and honored to share the news of this investment from Oncology Ventures, an organization that joins in our commitment to pushing the boundaries of healthcare innovation. This collaboration aligns with our goal of seeking out partners that prioritize the well-being of patients, including accessibility and overall satisfaction of care. We believe this investment will make a meaningful impact on the way cancer care is experienced, from both a patient and a physician perspective.”
— Dan Nardi, CEO of Reimagine Care
“Reimagine Care aligns perfectly with Oncology Ventures’ thesis on better utilizing data and technology to improve patient outcomes and experience, while reducing costs for key industry stakeholders. We are excited to partner with Dan and the Reimagine Care team as they continue to work with leading institutions, like City of Hope and The Center for Cancer and Blood Disorders, and additional strategics, helping to provide true value-based care.”
— Ben Freeberg, Founder and Managing Partner of Oncology Ventures
